252 related articles for article (PubMed ID: 31245977)
41. Abnormal fundus autofluorescence results of patients in long-term treatment with deferoxamine.
Viola F; Barteselli G; Dell'arti L; Vezzola D; Villani E; Mapelli C; Zanaboni L; Cappellini MD; Ratiglia R
Ophthalmology; 2012 Aug; 119(8):1693-700. PubMed ID: 22480740
[TBL] [Abstract][Full Text] [Related]
42. Hydroxychloroquine toxicity despite normal dose therapy.
Falcone PM; Paolini L; Lou PL
Ann Ophthalmol; 1993 Oct; 25(10):385-8. PubMed ID: 8304691
[TBL] [Abstract][Full Text] [Related]
43. Assessment of hydroxychloroquine maculopathy after cessation of treatment: an optical coherence tomography and multifocal electroretinography study.
Moschos MM; Nitoda E; Chatziralli IP; Gatzioufas Z; Koutsandrea C; Kitsos G
Drug Des Devel Ther; 2015; 9():2993-9. PubMed ID: 26089648
[TBL] [Abstract][Full Text] [Related]
44. Retinal toxicity related to hydroxychloroquine in patients with systemic lupus erythematosus and rheumatoid arthritis.
Telek HH; Yesilirmak N; Sungur G; Ozdemir Y; Yesil NK; Ornek F
Doc Ophthalmol; 2017 Dec; 135(3):187-194. PubMed ID: 28852896
[TBL] [Abstract][Full Text] [Related]
45. Visual Field Sensitivity Prediction Using Optical Coherence Tomography Analysis in Hydroxychloroquine Toxicity.
Jayakar G; De Silva T; Cukras CA
Invest Ophthalmol Vis Sci; 2022 Jan; 63(1):15. PubMed ID: 35015028
[TBL] [Abstract][Full Text] [Related]
46. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal.
Mavrikakis I; Sfikakis PP; Mavrikakis E; Rougas K; Nikolaou A; Kostopoulos C; Mavrikakis M
Ophthalmology; 2003 Jul; 110(7):1321-6. PubMed ID: 12867385
[TBL] [Abstract][Full Text] [Related]
47. Impact of the revised american academy of ophthalmology guidelines regarding hydroxychloroquine screening on actual practice.
Browning DJ
Am J Ophthalmol; 2013 Mar; 155(3):418-428.e1. PubMed ID: 23218706
[TBL] [Abstract][Full Text] [Related]
48. Hydroxychloroquine and chloroquine retinopathy: a systematic review evaluating the multifocal electroretinogram as a screening test.
Tsang AC; Ahmadi Pirshahid S; Virgili G; Gottlieb CC; Hamilton J; Coupland SG
Ophthalmology; 2015 Jun; 122(6):1239-1251.e4. PubMed ID: 25824328
[TBL] [Abstract][Full Text] [Related]
49. Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography.
Lyons JS; Severns ML
Am J Ophthalmol; 2007 May; 143(5):801-809. PubMed ID: 17336914
[TBL] [Abstract][Full Text] [Related]
50. Value of Microperimetry in Detecting Early Retinal Toxicity of Hydroxychloroquine in Children with Juvenile Systemic Lupus Erythematosus.
Youssef MM; El-Fayoumi D; Sidky MK; Hegazy AI; Marzouk H; Eltanamly RM
Ophthalmologica; 2017; 237(3):180-184. PubMed ID: 28297699
[TBL] [Abstract][Full Text] [Related]
51. Macula pigment optical densitometry changes in hydroxychloroquine use.
Kabataş N; Özateş S; Avarisli NA; Kakil SB; Özişler C
Cutan Ocul Toxicol; 2021 Jun; 40(2):115-118. PubMed ID: 33757380
[TBL] [Abstract][Full Text] [Related]
52. Screening for chloroquine maculopathy in populations with uncertain reliability in outcomes of automatic visual field testing.
Kunavisarut P; Chavengsaksongkram P; Rothova A; Pathanapitoon K
Indian J Ophthalmol; 2016 Oct; 64(10):710-714. PubMed ID: 27905330
[TBL] [Abstract][Full Text] [Related]
53. Imaging of Hydroxychloroquine Toxicity with Fluorescence Lifetime Imaging Ophthalmoscopy.
Sauer L; Calvo CM; Vitale AS; Henrie N; Milliken CM; Bernstein PS
Ophthalmol Retina; 2019 Oct; 3(10):814-825. PubMed ID: 31345727
[TBL] [Abstract][Full Text] [Related]
54. Correlation between fundus autofluorescence and central visual function in chronic central serous chorioretinopathy.
Eandi CM; Piccolino FC; Alovisi C; Tridico F; Giacomello D; Grignolo FM
Am J Ophthalmol; 2015 Apr; 159(4):652-8. PubMed ID: 25555802
[TBL] [Abstract][Full Text] [Related]
55. Topiramate maculopathy.
Gualtieri W; Janula J
Int Ophthalmol; 2013 Feb; 33(1):103-6. PubMed ID: 23015022
[TBL] [Abstract][Full Text] [Related]
56. Selective thinning of the perifoveal inner retina as an early sign of hydroxychloroquine retinal toxicity.
Pasadhika S; Fishman GA; Choi D; Shahidi M
Eye (Lond); 2010 May; 24(5):756-62; quiz 763. PubMed ID: 20395978
[TBL] [Abstract][Full Text] [Related]
57. Pericentral retinopathy and racial differences in hydroxychloroquine toxicity.
Melles RB; Marmor MF
Ophthalmology; 2015 Jan; 122(1):110-6. PubMed ID: 25182842
[TBL] [Abstract][Full Text] [Related]
58. A comparison of structural and functional changes in patients screened for hydroxychloroquine retinopathy.
Greenstein VC; Amaro-Quireza L; Abraham ES; Ramachandran R; Tsang SH; Hood DC
Doc Ophthalmol; 2015 Feb; 130(1):13-23. PubMed ID: 25502494
[TBL] [Abstract][Full Text] [Related]
59. Structural Retinal Assessment Using Optical Coherence Tomography and Fundus Fluorescein Angiography in Systemic Lupus Erythematosus Patients.
Fouad SA; Esmat Mahmoud Ali SM; Rezk Alnaggar ARL; Mahfouz S; Essam M; El-Gendy H
J Clin Rheumatol; 2021 Jan; 27(1):34-39. PubMed ID: 31688343
[TBL] [Abstract][Full Text] [Related]
60. Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema.
Vujosevic S; Torresin T; Bini S; Convento E; Pilotto E; Parrozzani R; Midena E
Acta Ophthalmol; 2017 Aug; 95(5):464-471. PubMed ID: 27775223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
